The pharmacological management of gambling disorder : if, when, and how
INTRODUCTION: Gambling disorder (GD) consists of a persistent, recurrent pattern of gambling that is associated with substantial distress or impairment. The etiology is multifactorial. GD frequently co-occurs with other psychiatric disorders and is often untreated. Different psychosocial interventions, particularly cognitive-behavioral therapy, are useful in the treatment of GD. Pharmacological therapy may also be helpful . No formal guidelines exist, and the management of the disease is often guided by few clinical elements.
AREAS COVERED: A literature search was performed using PubMed, Scopus, and Web of Science databases about treatment options for GD, considering both psychosocial treatments and available pharmacological ones.
EXPERT OPINION: The authors address whether and when it is appropriate to initiate pharmacological treatment for GD. They focus on providing clinicians with guidance on how to approach patients with GD in those situations where pharmacological therapy may be necessary. The reasons for the clinician to start thinking about a medication are examined. As specific traits in the psychopathology of GD may be managed with a strategic choice of the pharmacologic agent, the different available options are analyzed on the basis of their potential usefulness in GD. Issues that remain open about the pharmacological management of GD are summarized.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
|---|---|
| Enthalten in: |
Expert opinion on pharmacotherapy - 24(2023), 4 vom: 04. März, Seite 419-423 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Pettorruso, Mauro [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Behavioral addiction |
|---|
| Anmerkungen: |
Date Completed 29.03.2023 Date Revised 29.03.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/14656566.2023.2172329 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM352010304 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM352010304 | ||
| 003 | DE-627 | ||
| 005 | 20231226052739.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/14656566.2023.2172329 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1173.xml |
| 035 | |a (DE-627)NLM352010304 | ||
| 035 | |a (NLM)36690348 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Pettorruso, Mauro |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The pharmacological management of gambling disorder |b if, when, and how |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.03.2023 | ||
| 500 | |a Date Revised 29.03.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a INTRODUCTION: Gambling disorder (GD) consists of a persistent, recurrent pattern of gambling that is associated with substantial distress or impairment. The etiology is multifactorial. GD frequently co-occurs with other psychiatric disorders and is often untreated. Different psychosocial interventions, particularly cognitive-behavioral therapy, are useful in the treatment of GD. Pharmacological therapy may also be helpful . No formal guidelines exist, and the management of the disease is often guided by few clinical elements | ||
| 520 | |a AREAS COVERED: A literature search was performed using PubMed, Scopus, and Web of Science databases about treatment options for GD, considering both psychosocial treatments and available pharmacological ones | ||
| 520 | |a EXPERT OPINION: The authors address whether and when it is appropriate to initiate pharmacological treatment for GD. They focus on providing clinicians with guidance on how to approach patients with GD in those situations where pharmacological therapy may be necessary. The reasons for the clinician to start thinking about a medication are examined. As specific traits in the psychopathology of GD may be managed with a strategic choice of the pharmacologic agent, the different available options are analyzed on the basis of their potential usefulness in GD. Issues that remain open about the pharmacological management of GD are summarized | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Behavioral addiction | |
| 650 | 4 | |a comorbidity | |
| 650 | 4 | |a gambling disorder | |
| 650 | 4 | |a psychopharmacology | |
| 650 | 4 | |a treatment | |
| 700 | 1 | |a Di Carlo, Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Romeo, Vincenzo Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Jimenez-Murcia, Susana |e verfasserin |4 aut | |
| 700 | 1 | |a Grant, Jon E |e verfasserin |4 aut | |
| 700 | 1 | |a Martinotti, Giovanni |e verfasserin |4 aut | |
| 700 | 1 | |a Di Giannantonio, Massimo |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Expert opinion on pharmacotherapy |d 1999 |g 24(2023), 4 vom: 04. März, Seite 419-423 |w (DE-627)NLM111602130 |x 1744-7666 |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2023 |g number:4 |g day:04 |g month:03 |g pages:419-423 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/14656566.2023.2172329 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 24 |j 2023 |e 4 |b 04 |c 03 |h 419-423 | ||